Market Research Logo

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides an overview of Breast Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Breast Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Breast Cancer Diagnostic Tests Overview
  • Products under Development
    • Breast Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Figure 1: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Breast Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
    • Breast Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Figure 2: Breast Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Breast Cancer Diagnostic Tests - Pipeline Products by Territory
    • Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Figure 3: Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
    • Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
    • Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Figure 5: Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
  • Breast Cancer Diagnostic Tests - Pipeline Products under Development by Companies
    • Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
      • Table Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
    • Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
  • Breast Cancer Diagnostic Tests Companies and Product Overview
    • 2X Oncology Inc Company Overview
      • 2X Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 2X Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 2X-121 Companion Diagnostic Assay - Product Status
        • Table 2X-121 Companion Diagnostic Assay - Product Description
    • A&G Pharmaceutical Inc Company Overview
      • A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onco 88 - Breast Cancer - Product Status
        • Table Onco 88 - Breast Cancer - Product Description
        • Table OncoStain 88 - Breast Cancer - Product Status
        • Table OncoStain 88 - Breast Cancer - Product Description
    • Abviva, Inc. Company Overview
      • Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Mammastatin - Product Status
        • Table Diagnostic Assay - Mammastatin - Product Description
    • Accelerated Medical Diagnostics Company Overview
      • Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - Oxaliplatin - Product Status
        • Table Companion Diagnostic Test - Oxaliplatin - Product Description
    • Acobiom Company Overview
      • Acobiom Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acobiom Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acobiom Companion Diagnostic Test - Breast Cancer - Product Status
        • Table Acobiom Companion Diagnostic Test - Breast Cancer - Product Description
        • Table Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
        • Table Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
        • Table Diagnostic/Prognostic Assay - Breast Cancer - Product Status
        • Table Diagnostic/Prognostic Assay - Breast Cancer - Product Description
    • Affichem SA Company Overview
      • Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table AF300 Based Chromatographic Kit - Product Status
        • Table AF300 Based Chromatographic Kit - Product Description
        • Table AF300 Based Enzymatic Immunoassay Kit - Product Status
        • Table AF300 Based Enzymatic Immunoassay Kit - Product Description
    • AIT Austrian Institute of Technology GmbH Company Overview
      • AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AIT Austrian Institute of Technology GmbH Diagnostic Assay - Breast Cancer - Product Status
        • Table AIT Austrian Institute of Technology GmbH Diagnostic Assay - Breast Cancer - Product Description
    • Albert Ludwigs University of Freiburg Company Overview
      • Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
        • Table Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
        • Table mRNA Based Diagnostic Assay - Breast Cancer - Product Status
        • Table mRNA Based Diagnostic Assay - Breast Cancer - Product Description
    • Alere Inc Company Overview
      • Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NMP66 Test - Product Status
        • Table NMP66 Test - Product Description
    • Almac Diagnostics Ltd Company Overview
      • Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
        • Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
    • Amarantus Bioscience Holdings Inc Company Overview
      • Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuroPro - Breast Cancer - Product Status
        • Table NuroPro - Breast Cancer - Product Description
    • AngioGenex Inc Company Overview
      • AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status
        • Table Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description
        • Table Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
        • Table Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
        • Table Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
        • Table Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
        • Table Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Status
        • Table Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Description
        • Table Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
        • Table Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
    • ANGLE plc Company Overview
      • ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Parsortix-Based Test - Breast Cancer - Product Status
        • Table Parsortix-Based Test - Breast Cancer - Product Description
    • Anixa Diagnostics Corporation Company Overview
      • Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anixa Diagnostics Corporation Biomarker Test - Breast Cancer - Product Status
        • Table Anixa Diagnostics Corporation Biomarker Test - Breast Cancer - Product Description
    • Armune BioScience Inc Company Overview
      • Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Armune BioScience Inc Diagnostic Test - Breast Cancer - Product Status
        • Table Armune BioScience Inc Diagnostic Test - Breast Cancer - Product Description
    • Arno Therapeutics Inc Company Overview
      • Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Activated Estrogen Receptor Biomarker Assay - Product Status
        • Table Activated Estrogen Receptor Biomarker Assay - Product Description
        • Table Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status
        • Table Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description
    • ArtemixRx Company Overview
      • ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
        • Table ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
        • Table ArtemixRx Prognostic Test - Breast Cancer - Product Status
        • Table ArtemixRx Prognostic Test - Breast Cancer - Product Description
    • Ascendant Diagnostics, LLC Company Overview
      • Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table MelodyDX - Product Status
        • Table MelodyDX - Product Description
    • Assurance Biosciences, Inc. (Inactive) Company Overview
      • Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Salivary-Based Assay - Breast Cancer - Product Status
        • Table Salivary-Based Assay - Breast Cancer - Product Description
    • Atossa Genetics Inc Company Overview
      • Atossa Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atossa Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atossa Genetics Inc ArgusCYTE Breast Health Test - Product Status
        • Table Atossa Genetics Inc ArgusCYTE Breast Health Test - Product Description
        • Table Atossa Genetics Inc Companion Diagnostic Test - Breast Cancer - Product Status
        • Table Atossa Genetics Inc Companion Diagnostic Test - Breast Cancer - Product Description
        • Table Atossa Genetics Inc Companion Diagnostic Test - PED - Product Status
        • Table Companion Diagnostic Test - PED - Product Description
        • Table Next Generation MASCT System - Product Status
        • Table Next Generation MASCT System - Product Description
        • Table NextCYTE Breast Cancer Test - Product Status
        • Table NextCYTE Breast Cancer Test - Product Description
    • Aurelium BioPharma Inc. Company Overview
      • Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Screening Test - Product Status
        • Table Breast Cancer Screening Test - Product Description
        • Table MMD ELISA Test - Breast Cancer - Product Status
        • Table MMD ELISA Test - Breast Cancer - Product Description
    • Autoimmune Technologies LLC Company Overview
      • Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Autoimmune Technologies LLC Diagnostic Assay - Breast Cancer - Product Status
        • Table Autoimmune Technologies LLC Diagnostic Assay - Breast Cancer - Product Description
    • Avant Diagnostics, Inc. Company Overview
      • Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Status
        • Table Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Description
    • Ayanda Biosystems SA (Inactive) Company Overview
      • Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ayanda Biosystems SA (Inactive) Diagnostic Test - Breast Cancer - Product Status
        • Table Ayanda Biosystems SA (Inactive) Diagnostic Test - Breast Cancer - Product Description
    • Baylor College of Medicine Company Overview
      • Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Status
        • Table Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Description
    • BCAL Diagnostics Pty Limited Company Overview
      • BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table BCAL Test - Breast Cancer - Product Status
        • Table BCAL Test - Breast Cancer - Product Description
    • Becton Dickinson and Co Company Overview
      • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Diagnostic Test - Breast Cancer - Product Status
        • Table Becton Dickinson and Co Diagnostic Test - Breast Cancer - Product Description
    • Biocartis SA Company Overview
      • Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Idylla Liquid Biopsy Test - Breast Cancer - Product Status
        • Table Idylla Liquid Biopsy Test - Breast Cancer - Product Description
        • Table Idylla Solid Biopsy Test - Breast Cancer - Product Status
        • Table Idylla Solid Biopsy Test - Breast Cancer - Product Description
    • Biocrates Life Sciences AG Company Overview
      • Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomic Biomarker Assay - Breast Cancer - Product Status
        • Table Metabolomic Biomarker Assay - Breast Cancer - Product Description
    • Biodesix Inc Company Overview
      • Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeriStrat - Breast Cancer - Product Status
        • Table VeriStrat - Breast Cancer - Product Description
    • BioGenex Laboratories Inc Company Overview
      • BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IHC System - Breast Cancer - Product Status
        • Table IHC System - Breast Cancer - Product Description
    • BioMarCare Technologies Ltd Company Overview
      • BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast PARpanel Biopsy - Product Status
        • Table Breast PARpanel Biopsy - Product Description
        • Table Breast PARpanel Blood - Product Status
        • Table Breast PARpanel Blood - Product Description
    • BioMark Diagnostics Inc. Company Overview
      • BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomics-based Diagnostic Assay - Breast Cancer - Product Status
        • Table Metabolomics-based Diagnostic Assay - Breast Cancer - Product Description
    • BioMarker Strategies LLC Company Overview
      • BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarker Strategies LLC Ex Vivo Biomarker Test - Breast Cancer - Product Status
        • Table BioMarker Strategies LLC Ex Vivo Biomarker Test - Breast Cancer - Product Description
    • bioMerieux S.A. Company Overview
      • bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
        • Table Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
    • Biomoda, Inc. (Inactive) Company Overview
      • Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CyPath Diagnostic Assay - Breast Cancer - Product Status
        • Table CyPath Diagnostic Assay - Breast Cancer - Product Description
    • Bioprognos SL Company Overview
      • Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table MBDAA Breast Cancer Test - Product Status
        • Table MBDAA Breast Cancer Test - Product Description
    • Biosceptre International Ltd Company Overview
      • Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer IHC Diagnostic Test - Product Status
        • Table Breast Cancer IHC Diagnostic Test - Product Description
    • BioSystems International Company Overview
      • BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioSystems International Diagnostic Test - Breast Cancer - Product Status
        • Table BioSystems International BioSystems International Diagnostic Test - Breast Cancer - Product Description
    • BioTime Inc Company Overview
      • BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Confirmatory Diagnostic Blood Test - Breast Cancer - Product Status
        • Table Confirmatory Diagnostic Blood Test - Breast Cancer - Product Description
    • Caprion Biosciences Inc Company Overview
      • Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Caprion Biosciences Inc Diagnostic Assay - Breast Cancer - Product Status
        • Table Caprion Biosciences Inc Diagnostic Assay - Breast Cancer - Product Description
    • Celcuity LLC Company Overview
      • Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CELx HSF Test - Product Status
        • Table CELx HSF Test - Product Description
        • Table CELx Test - Breast Cancer - Product Status
        • Table CELx Test - Breast Cancer - Product Description
    • Cellanyx Diagnostics, Inc. Company Overview
      • Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellanyx Test - Breast Cancer - Product Status
        • Table Cellanyx Test - Breast Cancer - Product Description
    • CellMax Life Company Overview
      • CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellmax Protect - Breast Cancer - Product Status
        • Table Cellmax Protect - Breast Cancer - Product Description
    • CellXplore, Inc. Company Overview
      • CellXplore, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellXplore, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellXplore, Inc. Diagnostic Assay - Breast Cancer - Product Status
        • Table CellXplore, Inc. Diagnostic Assay - Breast Cancer - Product Description
    • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview
      • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker - Early Stage Breast Cancer - Product Status
        • Table Biomarker - Early Stage Breast Cancer - Product Description
    • Cepheid Company Overview
      • Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table XPERT Breast CA Monitoring Test - Product Status
        • Table XPERT Breast CA Monitoring Test - Product Description
        • Table Xpert Breast Recurrence Signature Assay - Product Status
        • Table Xpert Breast Recurrence Signature Assay - Product Description
        • Table Xpert Breast Therapy Stratifier Assay - Product Status
        • Table Xpert Breast Therapy Stratifier Assay - Product Description
    • Ceres Nanosciences Inc Company Overview
      • Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotrap Breast Cancer Biomarker Test - Product Status
        • Table Nanotrap Breast Cancer Biomarker Test - Product Description
    • Cernostics Inc. Company Overview
      • Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table TissueCypher Breast Cancer Test - Product Status
        • Table TissueCypher Breast Cancer Test - Product Description
    • China Sky One Medical Inc Company Overview
      • China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Diagnostic Kit - Breast Cancer - Product Status
        • Table China Sky One Medical Inc Diagnostic Kit - Breast Cancer - Product Description
    • Chronix Biomedical Inc Company Overview
      • Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chronix Biomedical Inc Companion Diagnostic Test - Breast Cancer - Product Status
        • Table Chronix Biomedical Inc Companion Diagnostic Test - Breast Cancer - Product Description
    • Clarient Inc Company Overview
      • Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mammotax - Product Status
        • Table Mammotax - Product Description
    • Cleveland Diagnostics Inc. Company Overview
      • Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cleveland Diagnostics Inc. Blood-Based Diagnostic Test - Breast Cancer - Product Status
        • Table Cleveland Diagnostics Inc. Blood-Based Diagnostic Test - Breast Cancer - Product Description
    • CompanDX Ltd. Company Overview
      • CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompanDX Ltd. Biomarker Assay - Breast Cancer - Product Status
        • Table CompanDX Ltd. Biomarker Assay - Breast Cancer - Product Description
    • Courtagen Life Sciences Inc Company Overview
      • Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Diagnostic Panel - Product Status
        • Table Breast Cancer Diagnostic Panel - Product Description
    • Da An Gene Co Ltd Company Overview
      • Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Real Time PCR Kit - ER - Product Status
        • Table Real Time PCR Kit - ER - Product Description
    • Dana-Farber Cancer Institute Inc Company Overview
      • Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dana-Farber Cancer Institute Inc Biomarker Assay - Breast Cancer - Product Status
        • Table Dana-Farber Cancer Institute Inc Biomarker Assay - Breast Cancer - Product Description
    • Dartmouth College Company Overview
      • Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
        • Table ISH/IHC Assay - Breast Cancer - Product Status
        • Table ISH/IHC Assay - Breast Cancer - Product Description
    • Diaxonhit SA Company Overview
      • Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diaxonhit SA Companion Diagnostic Test - Breast Cancer - Product Status
        • Table Diaxonhit SA Companion Diagnostic Test - Breast Cancer - Product Description
        • Table EHT Dx 11 - Product Status
        • Table EHT Dx 11 - Product Description
        • Table EHT Dx14 - Product Status
        • Table EHT Dx14 - Product Description
    • Dublin City University Company Overview
      • Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Based Assay - Breast Cancer - Product Status
        • Table Biomarker Based Assay - Breast Cancer - Product Description
    • Eventus Diagnostics Inc (Inactive) Company Overview
      • Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Octava Blue Test - Product Status
        • Table Octava Blue Test - Product Description
        • Table Octava Pink Test - Product Status
        • Table Octava Pink Test - Product Description
        • Table Eventus Diagnostics Inc (Inactive) - Ongoing Clinical Trials Overview
        • Table Octava Pink Test - OctavaPink for Dense Breast after Negative Mammography
    • Exosomics Siena SpA Company Overview
      • Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ExoTEST Breast - Product Status
        • Table ExoTEST Breast - Product Description
    • Fahy Gurteen UK Ltd Company Overview
      • Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Breast Cancer - Product Status
        • Table Diagnostic Test - Breast Cancer - Product Description
    • Fina Biotech SL Company Overview
      • Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dx Bioenergetic Signature - Breast Cancer - Product Status
        • Table Dx Bioenergetic Signature - Breast Cancer - Product Description
    • Fluxion Biosciences Inc Company Overview
      • Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluxion Breast Cancer Test - Product Status
        • Table Fluxion Breast Cancer Test - Product Description
    • Fournira Optime Diagnostics Company Overview
      • Fournira Optime Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fournira Optime Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fournira Diagnostic Kit - Breast Cancer - Product Status
        • Table Fournira Diagnostic Kit - Breast Cancer - Product Description
    • French National Institute of Health and Medical Research Company Overview
      • French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table French National Institute of Health and Medical Research Diagnostic Assay - Breast Cancer - Product Status
        • Table French National Institute of Health and Medical Research Diagnostic Assay - Breast Cancer - Product Description
        • Table PTPL1 Based Prognostic Assay - Breast Cancer - Product Status
        • Table PTPL1 Based Prognostic Assay - Breast Cancer - Product Description
    • Genome Diagnostics Pvt. Ltd. Company Overview
      • Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Her-2 neu Real Time PCR Kit - Product Status
        • Table Her-2 neu Real Time PCR Kit - Product Description
    • Genomic Health Inc Company Overview
      • Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oncotype DX IVD Test - Product Status
        • Table Oncotype DX IVD Test - Product Description
    • GenomicTree Inc Company Overview
      • GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyTect Breast Cancer - Product Status
        • Table EarlyTect Breast Cancer - Product Description
    • Genoptix Inc Company Overview
      • Genoptix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genoptix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Estrogen Receptor Assay - Product Status
        • Table Estrogen Receptor Assay - Product Description
        • Table HER2 Receptor Assay - Product Status
        • Table HER2 Receptor Assay - Product Description
    • George Washington University Company Overview
      • George Washington University Pipeline Products & Ongoing Clinical Trials Overview
        • Table George Washington University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based miRNA Assay - Breast Cancer - Product Status
        • Table Blood-Based miRNA Assay - Breast Cancer - Product Description
    • German Cancer Research Center Company Overview
      • German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Metastatic Breast Cancer - Product Status
        • Table Diagnostic Assay - Metastatic Breast Cancer - Product Description
        • Table Protein Biomarker Set - ER-alpha Positive Breast Cancer - Product Status
        • Table Protein Biomarker Set - ER-alpha Positive Breast Cancer - Product Description
    • Ghent University Company Overview
      • Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Test - Breast Cancer - Product Status
        • Table Prognostic Test - Breast Cancer - Product Description
    • GlycoZym Company Overview
      • GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlycoZym Diagnostic Assay - Breast Cancer - Product Status
        • Table GlycoZym Diagnostic Assay - Breast Cancer - Product Description
    • H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
      • H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc Diagnostic Assay - Breast Cancer - Product Status
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc Diagnostic Assay - Breast Cancer - Product Description
    • Hai Kang Life Corp Ltd Company Overview
      • Hai Kang Life Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hai Kang Life Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hai Kang Life Corp Ltd Diagnostic Test - Breast Cancer - Product Status
        • Table Hai Kang Life Corp Ltd Diagnostic Test - Breast Cancer - Product Description
    • Health Discovery Corp Company Overview
      • Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Health Discovery Corp Diagnostic Test - Breast Cancer - Product Status
        • Table Health Discovery Corp Diagnostic Test - Breast Cancer - Product Description
    • Hebrew University of Jerusalem Company Overview
      • Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody Based Diagnostic Assay - Breast Cancer - Product Status
        • Table Antibody Based Diagnostic Assay - Breast Cancer - Product Description
    • Heragen Inc Company Overview
      • Heragen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Heragen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Recurrence Test - Product Status
        • Table Breast Cancer Recurrence Test - Product Description
    • Hummingbird Diagnostics GmbH Company Overview
      • Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hummingbird Diagnostics GmbH Diagnostic Test - Breast Cancer - Product Status
        • Table Hummingbird Diagnostics GmbH Diagnostic Test - Breast Cancer - Product Description
    • Ikonisys Inc Company Overview
      • Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table oncoFISH breast - Product Status
        • Table oncoFISH breast - Product Description
    • Imagion Biosystems Inc Company Overview
      • Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagSense HER2+ Breast Cancer Test - Product Status
        • Table MagSense HER2+ Breast Cancer Test - Product Description
    • Immunovia AB Company Overview
      • Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table IMMray - Breast Cancer - Product Status
        • Table IMMray - Breast Cancer - Product Description
    • Insight Genetics Inc Company Overview
      • Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insight ALK ECD Assay - Product Status
        • Table Insight ALK ECD Assay - Product Description
    • Institute of Cancer Research Company Overview
      • Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table erbB2 Diagnostic Assay - Product Status
        • Table erbB2 Diagnostic Assay - Product Description
    • IRIS International Inc Company Overview
      • IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NADIA - Breast Cancer - Product Status
        • Table NADIA - Breast Cancer - Product Description
    • IV Diagnostics Inc Company Overview
      • IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Velox - Breast Cancer - Product Status
        • Table Velox - Breast Cancer - Product Description
    • John Hopkins University Company Overview
      • John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5hmC Marker Assay - Breast Cancer - Product Status
        • Table 5hmC Marker Assay - Breast Cancer - Product Description
        • Table Claudins Biomarker Assay - Product Status
        • Table Claudins Biomarker Assay - Product Description
        • Table Molecular Marker Detection Kit - Breast Cancer - Product Status
        • Table Molecular Marker Detection Kit - Breast Cancer - Product Description
    • Jonakee Cancer Research, Inc. Company Overview
      • Jonakee Cancer Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jonakee Cancer Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jonakee Cancer Research, Inc. Diagnostic Kit - Breast Cancer - Product Status
        • Table Jonakee Cancer Research, Inc. Diagnostic Kit - Breast Cancer - Product Description
    • Kailos Genetics, Inc. Company Overview
      • Kailos Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kailos Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ctDNA Test - Product Status
        • Table ctDNA Test - Product Description
    • Kalgene Pharmaceuticals Inc Company Overview
      • Kalgene Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kalgene Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Assay - Breast Cancer - Product Status
        • Table Companion Diagnostic Assay - Breast Cancer - Product Description
    • King Abdullah University of Science and Technology Company Overview
      • King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table King Abdullah University of Science and Technology Diagnostic Test - Breast Cancer - Product Status
        • Table King Abdullah University of Science and Technology Diagnostic Test - Breast Cancer - Product Description
    • Leica Biosystems GmbH Company Overview
      • Leica Biosystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Leica Biosystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neuvax Companion Diagnostic Assay - Product Status
        • Table Neuvax Companion Diagnostic Assay - Product Description
    • Louisville Bioscience, Inc. Company Overview
      • Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Remission pT Test - Product Status
        • Table Breast Cancer Remission pT Test - Product Description
    • MabCure Inc. Company Overview
      • MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MabCure Inc. Diagnostic Test - Breast Cancer - Product Status
        • Table MabCure Inc. Diagnostic Test - Breast Cancer - Product Description
    • Matrix-Bio, Inc. Company Overview
      • Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeraMarker BCD Test - Product Status
        • Table VeraMarker BCD Test - Product Description
        • Table VeraMarker BCD-Q Test - Product Status
        • Table VeraMarker BCD-Q Test - Product Description
        • Table VeraMarker Breast Cancer Test - Preoperative Chemotherapy - Product Status
        • Table VeraMarker Breast Cancer Test - Preoperative Chemotherapy - Product Description
    • MDNA Life Sciences Inc Company Overview
      • MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Mitomic Test - Product Status
        • Table Breast Mitomic Test - Product Description
    • MDxHealth SA Company Overview
      • MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table PharmacoDx - Breast Cancer - Product Status
        • Table PharmacoDx - Breast Cancer - Product Description
    • Medical Prognosis Institute A/S Company Overview
      • Medical Prognosis Institute A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical Prognosis Institute A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epirubicin Drug Response Predictor Assay - Product Status
        • Table Epirubicin Drug Response Predictor Assay - Product Description
        • Table Personalized Response Predictor (PRP) Biomarker Tool - Product Status
        • Table Personalized Response Predictor (PRP) Biomarker Tool - Product Description
    • MEDITE Cancer Diagnostics Inc Company Overview
      • MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Screening Assay - Breast Cancer - Product Status
        • Table Screening Assay - Breast Cancer - Product Description
    • MedMira Inc. Company Overview
      • MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Status
        • Table HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Description
    • Metabolomic Technologies Inc Company Overview
      • Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BreastDx - Product Status
        • Table BreastDx - Product Description
    • MetaStat Inc Company Overview
      • MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MenaCalc Breast - Product Status
        • Table MenaCalc Breast - Product Description
    • Milagen Inc Company Overview
      • Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunoassay - Breast Cancer - Product Status
        • Table Immunoassay - Breast Cancer - Product Description
    • Molecular Warehouse Ltd Company Overview
      • Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Warehouse Ltd Diagnostic Test - Breast Cancer - Product Status
        • Table Molecular Warehouse Ltd Diagnostic Test - Breast Cancer - Product Description
    • Morphotek Inc Company Overview
      • Morphotek Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Morphotek Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Assays - Folate Receptor Alpha (FRA) - Product Status
        • Table Companion Diagnostic Assays - Folate Receptor Alpha (FRA) - Product Description
    • Myriad Genetics Inc Company Overview
      • Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table myChoice HRD (Platinum) - Product Status
        • Table myChoice HRD (Platinum) - Product Description
        • Table Tumor BRACAnalysis CDx - Niraparib - Product Status
        • Table Tumor BRACAnalysis CDx - Niraparib - Product Description
        • Table Myriad Genetics Inc - Ongoing Clinical Trials Overview
        • Table myChoice HRD (Platinum) - A Randomized Phase II Study of Preoperative Cisplatin Versus Paclitaxel in Patients with Triple
        • Table Tumor BRACAnalysis CDx - Niraparib - A Phase III, Randomized, Open Label, Multi-center,
    • NanoString Technologies Inc Company Overview
      • NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - Enzalutamide - Product Status
        • Table Companion Diagnostic Test - Enzalutamide - Product Description
    • National University of Ireland Galway Company Overview
      • National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table microRNA Biomarker Assay - Breast Cancer - Product Status
        • Table microRNA Biomarker Assay - Breast Cancer - Product Description
    • New York University Company Overview
      • New York University Pipeline Products & Ongoing Clinical Trials Overview
        • Table New York University Pipeline Products & Ongoing Clinical Trials Overview
        • Table New York University Prognostic Test - Breast Cancer - Product Status
        • Table New York University Prognostic Test - Breast Cancer - Product Description
    • Newcastle University Company Overview
      • Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
        • Table SmartHEALTH POC System - Breast Cancer - Product Status
        • Table SmartHEALTH POC System - Breast Cancer - Product Description
    • Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
      • Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Tissue Biopsy Test - Product Status
        • Table Breast Tissue Biopsy Test - Product Description
        • Table NBT Diagnostic Test - Breast Cancer - Product Status
        • Table NBT Diagnostic Test - Breast Cancer - Product Description
    • Nuclea Biotechnologies Inc. (Inactive) Company Overview
      • Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Decision Dx - Breast Cancer - Product Status
        • Table Decision Dx - Breast Cancer - Product Description
        • Table Prognostic Assay - Breast Cancer - Product Status
        • Table Prognostic Assay - Breast Cancer - Product Description
        • Table USP2a Diagnostic Assay - Breast Cancer - Product Status
        • Table USP2a Diagnostic Assay - Breast Cancer - Product Description
    • Nuvera Biosciences Inc Company Overview
      • Nuvera Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuvera Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aromatase Inhibitor Biomarker - Companion Diagnostic Test - Product Status
        • Table Aromatase Inhibitor Biomarker - Companion Diagnostic Test - Product Description
        • Table Breast Cancer Chemotherapy Sensitivity - Product Status
        • Table Breast Cancer Chemotherapy Sensitivity - Product Description
        • Table Therapy-Resistance Diagnostic Test - Product Status
        • Table Therapy-Resistance Diagnostic Test - Product Description
    • Olink Proteomics AB Company Overview
      • Olink Proteomics AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Olink Proteomics AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Assay - Aromatase - Product Status
        • Table Companion Diagnostic Assay - Aromatase - Product Description
        • Table Companion Diagnostic Assay - Trastuzumab - Product Status
        • Table Companion Diagnostic Assay - Trastuzumab - Product Description
        • Table HER2-pEGFR Kit - Product Status
        • Table HER2-pEGFR Kit - Product Description
    • Olympia Diagnostics, Inc Company Overview
      • Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Olympia Diagnostics, Inc Prognostic Test - Breast Cancer - Product Status
        • Table Olympia Diagnostics, Inc Prognostic Test - Breast Cancer - Product Description
    • Oncimmune (USA) LLC Company Overview
      • Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyCDT - Breast Cancer - Product Status
        • Table EarlyCDT - Breast Cancer - Product Description
    • OncoCyte Corp Company Overview
      • OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Confirmatory BI RADS 3-4 Assay - Product Status
        • Table Breast Confirmatory BI RADS 3-4 Assay - Product Description
        • Table Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Status
        • Table Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Description
    • Onconome, Inc. (Inactive) Company Overview
      • Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Diagnostic Assay - Product Status
        • Table Breast Cancer Diagnostic Assay - Product Description
        • Table Breast Cancer Prognostic Assay - Product Status
        • Table Breast Cancer Prognostic Assay - Product Description
    • OncoStem Diagnostics Pvt. Ltd Company Overview
      • OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CanAssist - Triple-Negative Breast Cancer - Product Status
        • Table CanAssist - Triple-Negative Breast Cancer - Product Description
    • OncoVista Innovative Therapies Inc Company Overview
      • OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OVI-117 Biomarker - Breast Cancer - Product Status
        • Table OVI-117 Biomarker - Breast Cancer - Product Description
    • On-Q-ity, Inc. (Inactive) Company Overview
      • On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual-Capture Microfluidic Chip - Breast Cancer - Product Status
        • Table Dual-Capture Microfluidic Chip - Breast Cancer - Product Description
    • Orion Genomics LLC Company Overview
      • Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Diagnostic Test - Breast Cancer - Product Status
        • Table Orion Genomics LLC Diagnostic Test - Breast Cancer - Product Description
    • OTraces Inc. Company Overview
      • OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BC Sera Dx - Product Status
        • Table BC Sera Dx - Product Description
    • Oxford Impedance Diagnostics Ltd Company Overview
      • Oxford Impedance Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxford Impedance Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Based Test - Breast Cancer - Product Status
        • Table Biomarker Based Test - Breast Cancer - Product Description
    • PeriRx LLC Company Overview
      • PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Saliva Test - Breast Cancer - Product Status
        • Table Saliva Test - Breast Cancer - Product Description
    • Power3 Medical Products, Inc. Company Overview
      • Power3 Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Power3 Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BC-SeraPro - Product Status
        • Table BC-SeraPro - Product Description
    • Precision Biologics Inc Company Overview
      • Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Breast Cancer - Product Status
        • Table Diagnostic Assay - Breast Cancer - Product Description
    • PreMD Inc (Inactive) Company Overview
      • PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PreMD Diagnostic Test - Breast Cancer - Product Status
        • Table PreMD Diagnostic Test - Breast Cancer - Product Description
    • Princeton University Company Overview
      • Princeton University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Princeton University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Biomarker Test - Bone Metastasis - Product Status
        • Table Prognostic Biomarker Test - Bone Metastasis - Product Description
    • Proplex Technologies Llc Company Overview
      • Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Diagnostic Test - Breast Cancer - Product Status
        • Table Biomarker Diagnostic Test - Breast Cancer - Product Description
    • Protagen AG Company Overview
      • Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protagen AG Diagnostic Assay - Breast Cancer - Product Status
        • Table Protagen AG Diagnostic Assay - Breast Cancer - Product Description
    • Proteome Sciences Plc Company Overview
      • Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteome Sciences Plc Biomarker Panel - Breast Cancer - Product Status
        • Table Proteome Sciences Plc Biomarker Panel - Breast Cancer - Product Description
    • Proteomika Company Overview
      • Proteomika Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteomika Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteomika Biomarker Test - Breast Cancer - Product Status
        • Table Proteomika Biomarker Test - Breast Cancer - Product Description
    • Provista Diagnostics Inc Company Overview
      • Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Provista Diagnostics Inc Biomarker Test - Breast Cancer - Product Status
        • Table Provista Diagnostics Inc Biomarker Test - Breast Cancer - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Diagnostic Test - Breast Cancer - Product Status
        • Table Purdue University Purdue University Diagnostic Test - Breast Cancer - Product Description
    • Qiagen NV Company Overview
      • Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Biomarkers Test - Product Status
        • Table Breast Cancer Biomarkers Test - Product Description
    • Quest Diagnostics Inc Company Overview
      • Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeraMarker BCR Test - LDT - Product Status
        • Table VeraMarker BCR Test - LDT - Product Description
    • Rna Diagnostics Inc. Company Overview
      • Rna Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rna Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table RNA Disruption Assay - Breast Cancer - Product Status
        • Table RNA Disruption Assay - Breast Cancer - Product Description
        • Table Rna Diagnostics Inc. - Ongoing Clinical Trials Overview
        • Table RNA Disruption Assay - Breast Cancer - Breast Cancer Response Evaluation for Individualized Therapy: BREVITY
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bevacizumab Companion Diagnostic Assay - Product Status
        • Table Bevacizumab Companion Diagnostic Assay - Product Description
        • Table Diagnostic Test - Breast Cancer - Product Status
        • Table Diagnostic Test - Breast Cancer - Product Description
        • Table HER2 Expression/ Gene Amplification Pertuzumab - Product Status
        • Table HER2 Expression/ Gene Amplification Pertuzumab - Product Description
        • Table HER2 Expression/ Gene Amplification T-DM1 Diagnostic Test - Product Status
        • Table HER2 Expression/ Gene Amplification T-DM1 Diagnostic Test - Product Description
        • Table PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Status
        • Table PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Description
    • Rosetta Genomics Ltd Company Overview
      • Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prelude DCIS - Breast Cancer - Product Status
        • Table Prelude DCIS - Breast Cancer - Product Description
    • Royal College of Surgeons in Ireland Company Overview
      • Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Royal College of Surgeons in Ireland Diagnostic Test - Breast Cancer - Product Status
        • Table Royal College of Surgeons in Ireland Diagnostic Test - Breast Cancer - Product Description
    • RWTH Aachen University Company Overview
      • RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview
        • Table RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liquid Biopsy Test - Breast Cancer - Product Status
        • Table Liquid Biopsy Test - Breast Cancer - Product Description
    • Savicell Diagnostic Ltd. Company Overview
      • Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Savicell Well-Shield - Breast Cancer - Product Status
        • Table Savicell Well-Shield - Breast Cancer - Product Description
    • Selventa Inc Company Overview
      • Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Selventa Inc Biomarker Panel - Breast Cancer - Product Status
        • Table Selventa Inc Biomarker Panel - Breast Cancer - Product Description
    • Sengenics International Pte Ltd Company Overview
      • Sengenics International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sengenics International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sengenics Diagnostic Test - Breast Cancer - Product Status
        • Table Sengenics Diagnostic Test - Breast Cancer - Product Description
    • Siamab Therapeutics Inc Company Overview
      • Siamab Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siamab Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auto Antibody-Based Breast Cancer Test - Product Status
        • Table Auto Antibody-Based Breast Cancer Test - Product Description
    • Siemens Healthcare GmbH Company Overview
      • Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - Palbociclib - Product Status
        • Table Companion Diagnostic Test - Palbociclib - Product Description
    • Soricimed Biopharma Inc Company Overview
      • Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic SOR-D01 Assay - Breast Cancer - Product Status
        • Table Diagnostic SOR-D01 Assay - Breast Cancer - Product Description
        • Table Diagnostic SOR-D02 Assay - Breast Cancer - Product Status
        • Table Diagnostic SOR-D02 Assay - Breast Cancer - Product Description
    • Target Discovery Inc (Inactive) Company Overview
      • Target Discovery Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Target Discovery Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Isonostic Assay - Breast Cancer - Product Status
        • Table Isonostic Assay - Breast Cancer - Product Description
    • Taxor Diagnostics, LLC Company Overview
      • Taxor Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taxor Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taxor Diagnostics, LLC Diagnostic Test - Breast Cancer - Product Status
        • Table Taxor Diagnostics, LLC Diagnostic Test - Breast Cancer - Product Description
    • TechnoGenesys, Inc. Company Overview
      • TechnoGenesys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table TechnoGenesys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Akt Phosphorylation Test - Product Status
        • Table Akt Phosphorylation Test - Product Description
    • Treos Bio Inc Company Overview
      • Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyPEPI 914 CDx - Product Status
        • Table PolyPEPI 914 CDx - Product Description
    • Trinity College Dublin Company Overview
      • Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peptide Biomarker - Breast Cancer - Product Status
        • Table Peptide Biomarker - Breast Cancer - Product Description
    • Universal Diagnostics SL Company Overview
      • Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universal Diagnostics SL Blood-Based Diagnostic Test - Breast Cancer - Product Status
        • Table Universal Diagnostics SL Blood-Based Diagnostic Test - Breast Cancer - Product Description
    • University of Alberta Company Overview
      • University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Breast Cancer - Product Status
        • Table Diagnostic Assay - Breast Cancer - Product Description
    • University of Bergen Company Overview
      • University of Bergen Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Bergen Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Marker Test - Breast Cancer - Product Status
        • Table Prognostic Marker Test - Breast Cancer - Product Description
    • University of Bonn Company Overview
      • University of Bonn Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Bonn Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Bonn Diagnostic Test - Breast Cancer - Product Status
        • Table University of Bonn Diagnostic Test - Breast Cancer - Product Description
        • Table Prognostic Test - Breast Cancer - Product Status
        • Table Prognostic Test - Breast Cancer - Product Description
    • University of California Riverside Company Overview
      • University of California Riverside Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Riverside Pipeline Products & Ongoing Clinical Trials Overview
        • Table Circulating miRNA Test - Breast Cancer - Product Status
        • Table Circulating miRNA Test - Breast Cancer - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table sdAb Diagnostic Reagent - Product Status
        • Table sdAb Diagnostic Reagent - Product Description
    • University of Chicago Company Overview
      • University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRDS Predictive Marker - Breast Cancer - Product Status
        • Table IRDS Predictive Marker - Breast Cancer - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroRNA Assay - Breast Cancer - Product Status
        • Table MicroRNA Assay - Breast Cancer - Product Description
        • Table Multiplex ELISA Assay - Breast Cancer - Product Status
        • Table Multiplex ELISA Assay - Breast Cancer - Product Description
    • University of Iowa Company Overview
      • University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Diagnostic Test - Breast Cancer - Product Status
        • Table University of Iowa Diagnostic Test - Breast Cancer - Product Description
        • Table Prognostic Assay - Breast Cancer - Product Status
        • Table Prognostic Assay - Breast Cancer - Product Description
    • University of Kansas Company Overview
      • University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Ductal Carcinoma - Product Status
        • Table Diagnostic Assay - Ductal Carcinoma - Product Description
    • University of Lyon Company Overview
      • University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metastatic Relapse Biomarker - Breast Cancer - Product Status
        • Table Metastatic Relapse Biomarker - Breast Cancer - Product Description
    • University of Maryland Baltimore Company Overview
      • University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Kit - Metastatic Breast Cancer - Product Status
        • Table Prognostic Kit - Metastatic Breast Cancer - Product Description
    • University of Missouri Company Overview
      • University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table P-Scan Device - Product Status
        • Table P-Scan Device - Product Description
    • University of Nebraska Company Overview
      • University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker-Based Assay - Breast Cancer - Product Status
        • Table Biomarker-Based Assay - Breast Cancer - Product Description
    • University of Oxford Company Overview
      • University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metal Test - Breast Cancer - Product Status
        • Table Metal Test - Breast Cancer - Product Description
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Biomarker Test - Breast Cancer - Product Status
        • Table University of Pittsburgh Biomarker Test - Breast Cancer - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tumorigenic Marker - Breast Cancer - Product Status
        • Table Tumorigenic Marker - Breast Cancer - Product Description
    • University of Texas MD Anderson Cancer Center Company Overview
      • University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neo-Bioscore Staging System - Product Status
        • Table Neo-Bioscore Staging System - Product Description
    • University of Wisconsin Madison Company Overview
      • University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table REST Diagnostic Test - Breast Cancer - Product Status
        • Table REST Diagnostic Test - Breast Cancer - Product Description
    • US Biomarkers Inc Company Overview
      • US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Biomarker - Breast Cancer - Product Status
        • Table Blood-Based Biomarker - Breast Cancer - Product Description
    • Vermillion Inc Company Overview
      • Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vermillion Inc Biomarker Assay - Breast Cancer - Product Status
        • Table Vermillion Inc Biomarker Assay - Breast Cancer - Product Description
        • Table MammoCheck - Product Status
        • Table MammoCheck - Product Description
    • Viomics Inc. Company Overview
      • Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viomics Diagnostic Assay - Breast Cancer - Product Status
        • Table Viomics Diagnostic Assay - Breast Cancer - Product Description
    • Vitatex Inc. Company Overview
      • Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer CTC Detection Kit - Product Status
        • Table Breast Cancer CTC Detection Kit - Product Description
    • Vitruvian Biomedical Inc Company Overview
      • Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitruvian Biomedical Inc Diagnostic Assay - Breast Cancer - Product Status
        • Table Vitruvian Biomedical Inc Diagnostic Assay - Breast Cancer - Product Description
    • VolitionRX Ltd Company Overview
      • VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Status
        • Table NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Description
        • Table NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Status
        • Table NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Description
    • XEPTAGEN SpA Company Overview
      • XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table CA15.3 - IgM Kit - Product Status
        • Table CA15.3 - IgM Kit - Product Description
        • Table CEA - IgM Kit - Breast Cancer - Product Status
        • Table CEA - IgM Kit - Breast Cancer - Product Description
    • Xiamen Zeesan Biotech Co.,Ltd Company Overview
      • Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theranostic Test - Breast Cancer Recurrence Risk - Product Status
        • Table Theranostic Test - Breast Cancer Recurrence Risk - Product Description
    • Zetiq Technologies Ltd Company Overview
      • Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellDetect - Breast Cancer - Product Status
        • Table CellDetect - Breast Cancer - Product Description
  • Breast Cancer Diagnostic Tests - Recent Developments
    • Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research
    • Sep 12, 2017: Cernostics Announces Leadership Team Expansion
    • Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
    • Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses
    • Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
    • Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
    • Aug 30, 2017: bioMerieux - First-Half 2017 Results
    • Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
    • Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs
    • Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
    • Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes
    • Aug 24, 2017: AroCell: Interim report, Q2 2017
    • Aug 24, 2017: Sectra Signs Breast Imaging PACS Contract With UC San Diego Health
    • Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
    • Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
    • Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
    • Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
    • Aug 14, 2017: Atossa Genetics Announces Second Quarter 2017 Financial Results And Provides Company Update
    • Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
    • Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
    • Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results
    • Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
    • Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
    • Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results
    • Aug 01, 2017: Successful DRP prediction of patients treated with 2X-121, the PARP inhibitor recently licensed from Eisai
    • Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results
    • Aug 01, 2017: Proteome Sciences: Directorate changes
    • Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
    • Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
    • Jul 31, 2017: Sysmex America Completes Expansion of Reagents Manufacturing Facility, Opens Doors to Latin American Sales Office in Doral, Florida
    • Jul 28, 2017: Astellas Reports First Quarter FY2017 Financial Results
    • Jul 27, 2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017
    • Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
    • Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
    • Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017
    • Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
    • Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
    • Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
    • Jul 21, 2017: GSK announces Board and Committee changes
    • Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
    • Jul 19, 2017: Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination and Metastasis in a Mena-dependent Manner
    • Jul 18, 2017: 3N Diagnostics Announces Fortress Diagnostics will Manufacture Revolutionary Breast Cancer Test
    • Jul 18, 2017: Avant Diagnostics Highlights Published Clinical Utility Data for Theralink mTOR Pathway Activation Data Predicting Tamoxifen and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer
    • Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
    • Jul 18, 2017: Lew Titterton re-joins ITUS Board of Directors
    • Jul 17, 2017: Radiation Therapy Prior to Surgery Reduces the Risk of Secondary Tumors in Early-Stage Breast Cancer Patients
    • Jul 17, 2017: A swell diagnostic method
    • Jul 13, 2017: BioTime Subsidiary AgeX Therapeutics Appoints Aubrey de Grey, Ph.D. as VP of New Technology Discovery
    • Jul 10, 2017: Biocartis and ASTAR's ETPL initiate development of breast cancer assay to guide therapy selection
    • Jul 07, 2017: ITUS Appoints Dr. Amit Kumar as New CEO and Announces Management Changes
    • Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board
    • Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China
    • Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year
    • Jun 30, 2017: GeneNews Announces Election of Directors
    • Jun 29, 2017: MedMira Reports FY2017 Third Quarter Results
    • Jun 28, 2017: Pfizer breaks ground on new R&D facility in Missouri
    • Jun 27, 2017: Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri
    • Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
    • Jun 19, 2017: MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene
    • Jun 19, 2017: GSK confirms start date for Luke Miels
    • Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation
    • Jun 15, 2017: OncoCyte Reports Successful Completion of Follow on Breast Cancer Diagnostic Study
    • Jun 14, 2017: Rna Diagnostics Launches BREVITY - International Validation Trial of RDA in Breast Cancer
    • Jun 13, 2017: Almac Group Awarded U.S. Patents for Ground-breaking "DDRD" Assay
    • Jun 12, 2017: Proteome Sciences: New Registered Address
    • Jun 08, 2017: Siamab Therapeutics to Present at the 2017 BIO International Convention
    • Jun 08, 2017: Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy
    • Jun 06, 2017: BD Releases 2016 Sustainability Report
    • Jun 04, 2017: MPI - The efficacy of chemotherapy with epirubicin, one the of most used drugs in Breast Cancer can now be predicted by DRP - Poster published at ASCO
    • Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types
    • Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine
    • May 31, 2017: Astellas Announces New Global Website Launch
    • May 28, 2017: Oncocyte Continues to Make Progress Towards Commercialization; Reports First Quarter 2017 Results
    • May 23, 2017: New Study: Blood Test Offers Improved Breast Cancer Detection, New Tool to Reduce Use of Breast Biopsy
    • May 22, 2017: Diagnostic test for aggressive breast cancer achieves CE Marking
    • May 22, 2017: ASCO and the CAP Invite Comment on Focused Update to HER2 Testing Guideline in Breast Cancer
    • May 18, 2017: Biotheranostics Appoints Don Hardison as New Chief Executive Officer
    • May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results
    • May 11, 2017: Atossa Genetics Announces First Quarter 2017 Financial Results and Provides Company Update
    • May 11, 2017: Biocept Reports First Quarter 2017 Financial Results
    • May 11, 2017: Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas
    • May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update
    • May 11, 2017: Vermillion Reports First Quarter 2017 Results
    • May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update
    • May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
    • May 10, 2017: BioTime Reports First Quarter Results and Recent Corporate Accomplishments
    • May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors
    • May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights
    • May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress
    • May 08, 2017: MDxHealth Trading Update: January to April 2017
    • May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy
    • May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat's President and CEO to its Board of Directors
    • May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017
    • May 03, 2017: Clovis Oncology Announces First Quarter 2017 Operating Results
    • May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
    • May 02, 2017: Pfizer Reports First-Quarter 2017 Results
    • May 02, 2017: QIAGEN reports results for first quarter 2017
    • May 01, 2017: Rosetta Genomics Expands Patent Portfolio in Europe and Japan
    • Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
    • Apr 28, 2017: Astellas Announces Key Leadership Promotions in Development Organization
    • Apr 27, 2017: Astellas Pharma Announces Changes of Representative Directors and Directors
    • Apr 27, 2017: Astellas Reports Full Year FY2016 Financial Results
    • Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer
    • Apr 27, 2017: Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1
    • Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
    • Apr 26, 2017: GSK delivers another quarter of continued progress
    • Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
    • Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
    • Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
    • Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
    • Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review
    • Apr 14, 2017: Ipsen appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer
    • Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer
    • Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results
    • Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer
    • Apr 03, 2017: Caris Life Sciences' Results Demonstrate Ability of ADAPT Biotargeting System to Detect Breast Cancer Subtypes from Liquid Biopsy Samples
    • Mar 31, 2017: MedMira Reports FY2017 Second Quarter Results
    • Mar 30, 2017: Rosetta Genomics Reports 2016 Fourth Quarter and Full Year Financial Results
    • Mar 30, 2017: QIAGEN joins CANCER-ID consortium for liquid biopsy workflows
    • Mar 29, 2017: GeneNews Launches Blood-Based, Biomarker Test for Breast Cancer Risk Assessment
    • Mar 29, 2017: Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in `big data' pathology research
    • Mar 29, 2017: Vermillion Reports Fourth Quarter and Full Year 2016 Results
    • Mar 29, 2017: Sysmex America Announces Leadership Promotions
    • Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM
    • Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
    • Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results
    • Mar 21, 2017: Retractable Technologies Announces Litigation Updates
    • Mar 20, 2017: Study Results from Biodesix's Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber
    • Mar 16, 2017: GeneNews Announces Contract with Large Multi-Specialty Physician Group For Use of Early Cancer Diagnostic Tests
    • Mar 16, 2017: BioTime Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Accomplishments
    • Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update
    • Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors
    • Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors
    • Mar 03, 2017: Wistar'S Qihong Huang, M.D., Ph.D., Receives $50K Grant From The PA Breast Cancer Coalition For Novel Therapeutic Approach For Metastatic Breast Cancer
    • Mar 02, 2017: Ipsen appoints Benoit Hennion as Executive Vice President and President, Primary Care
    • Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook
    • Mar 01, 2017: bioMerieux - 2016 Financial Results
    • Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting
    • Feb 27, 2017: OncoCyte Reports Fourth Quarter and Full Year 2016 Financial Results
    • Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrates at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium
    • Feb 23, 2017: Ipsen delivers strong 2016 results and expects further sales growth and margin enhancement for 2017
    • Feb 23, 2017: MDxHealth Reports Financial Year 2016 Results
    • Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer's Board of Directors
    • Feb 22, 2017: Clovis Oncology Announces 2016 Operating Results
    • Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook
    • Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
    • Feb 21, 2017: BioTime Reports Pro Forma Gain on Deconsolidation of OncoCyte Subsidiary
    • Feb 17, 2017: A Novel, Quantitative Immunohistochemistry Method Enabled by BioGenex IHC System
    • Feb 16, 2017: AroCell: (publ) Year-End Report
    • Feb 16, 2017: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations
    • Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
    • Feb 15, 2017: Biocept Appoints Michael Terry Senior Vice President Commercial Operations
    • Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook
    • Feb 08, 2017: Astellas Announces Changes in Management Structure and Global Function
    • Feb 08, 2017: Astellas Announces Personnel Changes and Organizational Changes
    • Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
    • Feb 07, 2017: BioTime Appoints Industry Veteran, Stephana Patton, Ph.D., J.D., as General Counsel
    • Feb 06, 2017: Ipsen announces appointment of Dr. Sotirios G. Stergiopoulos as Head of Global Medical Affairs
    • Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter
    • Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016
    • Jan 31, 2017: Astellas Reports the First Nine Months Financial Results of FY2016
    • Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results
    • Jan 30, 2017: MedMira Announces AGM Results and Stock Option Grant
    • Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
    • Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
    • Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
    • Jan 26, 2017: Achievement of sales milestone for COPD products
    • Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback
    • Jan 24, 2017: DRP successfully predicts effect of 4 Breast Cancer drugs for Personalized Medicine
    • Jan 20, 2017: Ipsen appoints Harout Semerjian as President, Head of Specialty Care International Region & Global Franchises
    • Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review
    • Jan 19, 2017: Abbas Hussain to leave GSK
    • Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
    • Jan 10, 2017: OncoTAb Presentation to Highlight Results of Study on a Blood-Test Based Multi-Modal Screening Strategy for Early Breast Cancer Detection at Biotech Showcase Conference
    • Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016
    • Jan 09, 2017: MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO
    • Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results
    • Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition
    • Jan 04, 2017: OncoCyte Provides Updated Timelines on Diagnostic Test Development and Commercialization Plans
    • Dec 30, 2016: MedMira Reports 2017 First Quarter Financial Results
    • Dec 23, 2016: Atossa Genetics Appoints Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon) as Scientific Advisor
    • Dec 19, 2016: MetaStat Receives Additional State Clinical Laboratory Licenses
    • Dec 19, 2016: GSK announces Board changes
    • Dec 16, 2016: MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory
    • Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board
    • Dec 14, 2016: Natera Announces Participation In I-SPY 2 TRIAL For Breast Cancer
    • Dec 13, 2016: MetaStat Presents Positive Data from Two Clinical Studies of MetaSite Breast at 2016 San Antonio Breast Cancer Symposium
    • Dec 13, 2016: Provista Diagnostics Joins Cancer Moonshot-Inspired Collaborative to Advance Blood Tests for Cancer
    • Dec 12, 2016: Claude Bertrand to step down as Executive Vice President, R&D, Chief Scientific Officer of Ipsen
    • Dec 08, 2016: Astellas Research & Development Meeting Highlights
    • Dec 06, 2016: New blood-based diagnostic test for breast cancer demonstrates detection power of protein biomarkers irrespective of breast density
    • Dec 05, 2016: Biomarker tests in breast cancer: decision on chemotherapy remains difficult
    • Dec 02, 2016: Agendia's MammaPrint and BluePrint Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility
    • Nov 30, 2016: OncoStem Diagnostics launches CanAssist-Breast: an innovative Breast cancer recurrence prediction test
    • Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda
    • Nov 28, 2016: Myriad Genetics To Present Breast Cancer Studies on myChoice HRD at SABCS
    • Nov 28, 2016: MedMira Reports 2016 Fourth Quarter and Year End Financial Results
    • Nov 22, 2016: OGT announces commercial and financial highlights for FY 2016
    • Nov 21, 2016: Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire
    • Nov 17, 2016: AroCell: Interim report, 1 January - 30 September 2016
    • Nov 17, 2016: AroCell: Interim report January - September 2016
    • Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016
    • Nov 15, 2016: One thousand cancer patients have gene testing through efficient, affordable new process
    • Nov 14, 2016: Atossa Genetics Announces Third Quarter 2016 Financial Results and Provides Company Update
    • Nov 14, 2016: Vermillion appoints chief medical officer
    • Nov 14, 2016: HTG Molecular Diagnostics Reports Third Quarter 2016 Results
    • Nov 14, 2016: Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update
    • Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day
    • Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
    • Nov 10, 2016: Oncocyte Reports Third Quarter 2016 Financial Results
    • Nov 10, 2016: Vermillion Reports Third Quarter 2016 Results
    • Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update
    • Nov 09, 2016: Biocept Reports 2016 Third Quarter Financial Results
    • Nov 08, 2016: Oncocyte Promotes Lyndal Hesterberg to Senior Vice President, Research And Development
    • Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux
    • Nov 03, 2016: Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update
    • Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
    • Nov 03, 2016: BioTime Reports Third Quarter Results and Recent Clinical Progress
    • Nov 03, 2016: Genetic Counselor Mandate Creates a Barrier to BRCA1/2 Testing, New Study Finds
    • Nov 03, 2016: Ann Hammarstrand Appointed as New CFO to AroCell
    • Nov 02, 2016: MDxHealth Provides Third Quarter 2016 Business Update
    • Nov 02, 2016: Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
    • Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
    • Nov 02, 2016: NanoString Technologies Releases Operating Results for Third Quarter of 2016
    • Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017
    • Nov 01, 2016: Pfizer Reports Third-Quarter 2016 Results
    • Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results
    • Oct 27, 2016: Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications
    • Oct 27, 2016: Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year Outlook
    • Oct 27, 2016: Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors
    • Oct 26, 2016: NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016
    • Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
    • Oct 26, 2016: OncoDNA Signs Agreement with SOLTI to Provide Tumor Molecular Profile Analysis to Breast Cancer Patients in AGATA Screening Program
    • Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
    • Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
    • Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results
    • Oct 20, 2016: Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
    • Oct 11, 2016: Queen's And Almac Group In New Breast Cancer Discovery
    • Oct 07, 2016: Myriad Announces Poster Presentation on Tumor BRACAnalysis CDx test at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting
    • Oct 07, 2016: Myriad Announces Poster Presentations on myChoice HRD test at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting
    • Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
    • Sep 28, 2016: Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress
    • Sep 26, 2016: Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
    • Sep 26, 2016: Rosetta Genomics Reports 2016 Second Quarter Financial Results
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report